Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 252,097 | 0.1% | 556,064 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 239,882 | 0.1% | 612,507 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 322,794 | 0.2% | 725,055 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 392,333 | 0.3% | 809,234 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 354,462 | 0.2% | 880,214 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 450,128 | 0.3% | 967,851 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 474,372 | 0.3% | 1,012,058 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 493,399 | 0.3% | 1,180,353 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 616,770 | 0.5% | 1,515,816 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 525,074 | 0.5% | 1,509,961 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 516,469 | 0.4% | 1,467,618 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 466,223 | 0.4% | 1,479,745 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 447,042 | 0.4% | 1,548,037 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 521,134 | 0.5% | 1,799,868 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 528,945 | 0.5% | 1,877,088 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 496,509 | 0.4% | 1,902,551 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 425,765 | 0.3% | 1,938,819 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 363,926 | 0.3% | 2,006,318 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 402,135 | 0.3% | 1,994,418 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 431,695 | 0.3% | 2,008,913 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 498,315 | 0.4% | 2,108,468 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 588,118 | 0.5% | 2,161,244 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 632,680 | 0.6% | 2,179,324 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 138,696 | 0.2% | 582,880 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 132,677 | 0.1% | 605,969 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 47,031 | 0.1% | 719,690 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 48,109 | 0.1% | 651,790 | 12/31/2013 |